• Product NameDroxidopa
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityDroxidopa is a psychoactive drug and acts as a prodrug to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline).
• Target NameAdrenergic Receptor inhibitor
• CAS No. 23651-95-8
• Calculated MW 213.19
• Formulation C9H11NO5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O
  Pathways:Neuroscience; GPCR/G Protein
  Receptor:Adrenergic Receptor
  Boling pt:
  Melting pt:229-232C
  Solubility:Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
  Appearance:Off-white Color Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Mathias CJ. Clin Auton Res, 2008, 18 Suppl 1, 25-29.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting